WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
- Country
- πΊπΈUnited States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer
- First Posted Date
- 2008-08-11
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT00732082
- Locations
- πΊπΈ
Washington University, St. Louis, Missouri, United States
Sapropterin in Individuals With Phenylketonuria
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2018-06-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 45
- Registration Number
- NCT00730080
- Locations
- πΊπΈ
Washington University, Saint Louis, Missouri, United States
Oral Clofarabine for Acute Myeloid Leukemia
- First Posted Date
- 2008-08-04
- Last Posted Date
- 2014-11-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT00727766
- Locations
- πΊπΈ
Washington University, St. Louis, Missouri, United States
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
- Conditions
- First Posted Date
- 2008-07-30
- Last Posted Date
- 2018-06-18
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 255
- Registration Number
- NCT00725309
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States
Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2008-07-29
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT00723918
- Locations
- πΊπΈ
University of New York Downstate Medical Center, Brooklyn, New York, United States
πΊπΈUniversity of Rochester, Rochester, New York, United States
πΊπΈUniversity of California, San Diego, San Diego, California, United States
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
- Conditions
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 26
- Registration Number
- NCT00703625
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
- Conditions
- Interventions
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2013-05-24
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT00703170
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
Observational Study of Delayed Nausea and Vomiting
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2013-06-12
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 106
- Registration Number
- NCT00696280
- Locations
- πΊπΈ
Washington University School of Medicine, St. Louis, Missouri, United States
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
- Conditions
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 52
- Registration Number
- NCT00691938
- Locations
- πΊπΈ
Washington University, St. Louis, Missouri, United States
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2017-10-06
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 135
- Registration Number
- NCT00682786
- Locations
- πΊπΈ
Washington University School of Medicine, Saint Louis, Missouri, United States